Senate Aging Committee examines Alzheimer's in Washington
Former Supreme Court Justice Sandra Day O'Connor and former House Speaker Newt Gingrich, members of the Alzheimer's Study Group, testify about Alzheimer's disease as Alzheimer's Association supporters look on, before the Senate Special Committee on Aging on Capitol Hill in Washington on May 14, 2008. (UPI Photo/Roger L. Wollenberg)
Latest Headlines
Baxter International Inc. officials said its Phase III clinical study of immunoglobulin did not reduce cognitive decline in those with moderate Alzheimer's.
U.S. President Obama proposed Wednesday spending $31 billion for medical research in his 2014 National Institutes of Health budget.
Two studies indicate treatments of Alzheimer's are not effective unless the disease is found early, researchers reported in Vienna.
U.S. experts at the Alzheimer's Association offer help in differentiating between changes that come with aging and Alzheimer's disease.
Officials of the U.S. Alzheimer's Association say their round-the-clock help line receives more than a 30-percent increase in calls during the holidays.
U.S. researchers say they have found more evidence of a maternal genetic link to Alzheimer's disease.
U.S. medical scientists say a drug commonly prescribed to treat immunodeficiencies has shown promise as a treatment for Alzheimer's disease.
Researchers at Scotland's University of Aberdeen say a new drug they've developed holds great promise in slowing the progression of Alzheimer's disease.
An estimated 10 million baby boomers in the United States will develop Alzheimer's disease, the Alzheimer's Association said Tuesday.
By 2050, more than 106 million people worldwide are expected to have Alzheimer's disease, up from 26 million in 2006, U.S. researchers say.
